At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 1, 2026 at 19:00 ET
Multiple executives at Arcutis Biotherapeutics sold shares in a coordinated open-market transaction totaling $1.3M across four insiders, representing 0.04% of market cap. These sales coincided with routine stock award grants, a common practice around equity vesting events.
- Four insiders sold shares open-market for a total of $1,301,102 on March 2, 2026, at ~$25.16 per share
- Sellers include CFO Latha Vairavan and other named executive officers
- On February 27, the same insiders received stock awards totaling 196,000 shares (non-cash, $0 value)
- Total open-market sale value represents 0.04% of $3.1B market cap, below materiality threshold
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access